More competition in generic drugs could offer $800M in savings: study
Tuesday, November 25, 2008 - 16:35
in Mathematics & Economics
Making strategic changes to Canada's generic drug market could deliver up to $800 million in savings that could be returned to the consumer or reinvested in the healthcare system, according to a report released by the Competition Bureau Tuesday.